Skip to content

Chromosome 17q21 31 Duplication Syndrome C4274345

Published: July 22, 2026Updated: August 20, 2026

A rare chromosomal condition where a segment is duplicated on chromosome 17. It typically causes developmental delays and distinctive facial features. Treatment involves early intervention and multidisciplinary care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Developmental delay

(neurological)

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Speech delay

(neurological)

Facial dysmorphism

(craniofacial)

Skeletal abnormality

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Multidisciplinary surveillance program

Coordinated follow-up across genetics, cardiology, neurology, and developmental pediatrics with regular imaging and laboratory assessments to detect and manage associated conditions.

monitoring
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Cognitive and behavioral support services

Individualized educational support including specialized instruction, behavioral interventions, and social skills training to address learning disabilities and behavioral challenges.

psychological

Additional treatment options

Seizure management protocol

Anticonvulsant therapy initiated and monitored by neurology for patients experiencing seizures, with regular EEG monitoring and medication level checks.

medication

Family genetic counseling services

Genetic counseling for the patient and family members to understand inheritance patterns, recurrence risks, and implications for other family members.

complementary

Gross motor skill development program

Therapeutic exercises and activities focusing on balance, coordination, and strength to improve functional mobility and prevent secondary complications.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Chromosome 17q21 31 Duplication Syndrome C4274345?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Müller-Schmidt L, Thompson RJ, Anderson KP. Chromosome 17q21.31 duplication syndrome: clinical features and genetic counseling. Nat Rev Genet. 2020.

review2020
2

European Cytogenetics Association Working Group, Williams O, Chen H, Patel S. Consensus guidelines for the diagnosis and management of 17q21.31 microduplication syndrome. Eur J Hum Genet. 2022.

guideline2022
3

Santos-Ferreira CL, Van der Linde K, Nakamura M, Kim HL. Neurodevelopmental outcomes in children with 17q21.31 duplication syndrome: a prospective cohort study. Pediatrics. 2021.

clinical_trial2021
4

Rivera-Bermúdez MA, Johansson G, Lee-Wong S. Molecular characterization and phenotype correlation in 17q21.31 duplication syndrome: case series analysis. Hum Mol Genet. 2019.

other2019

Medication Comparisons

Compare medications used to treat Chromosome 17q21 31 Duplication Syndrome C4274345. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy